These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15254920)

  • 41. A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease--rivastigmine patch versus capsule.
    Winblad B; Cummings J; Andreasen N; Grossberg G; Onofrj M; Sadowsky C; Zechner S; Nagel J; Lane R
    Int J Geriatr Psychiatry; 2007 May; 22(5):456-67. PubMed ID: 17380489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of responders to rivastigmine: a prospective cohort study.
    Lemstra AW; Kuiper RB; Schmand B; van Gool WA
    Dement Geriatr Cogn Disord; 2008; 25(1):60-6. PubMed ID: 18033962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recruitment of volunteers to improve vitality in the elderly: the REVIVE study.
    Caplan GA; Harper EL
    Intern Med J; 2007 Feb; 37(2):95-100. PubMed ID: 17229251
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Are cholinergic enhancers beneficial for memory in schizophrenia? An event-related potentials (ERPs) study of rivastigmine add-on therapy in a crossover trial.
    Guillem F; Chouinard S; Poulin J; Godbout R; Lalonde P; Melun P; Bentaleb LA; Stip E
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):934-45. PubMed ID: 16580765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment.
    Dantoine T; Auriacombe S; Sarazin M; Becker H; Pere JJ; Bourdeix I
    Int J Clin Pract; 2006 Jan; 60(1):110-8. PubMed ID: 16409439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rivastigmine for subcortical vascular dementia.
    Román GC
    Expert Rev Neurother; 2005 May; 5(3):309-13. PubMed ID: 15938663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Delirium within three days of stroke in a cohort of elderly patients.
    Sheng AZ; Shen Q; Cordato D; Zhang YY; Yin Chan DK
    J Am Geriatr Soc; 2006 Aug; 54(8):1192-8. PubMed ID: 16913984
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Older adults discharged from the hospital with delirium: 1-year outcomes.
    McAvay GJ; Van Ness PH; Bogardus ST; Zhang Y; Leslie DL; Leo-Summers LS; Inouye SK
    J Am Geriatr Soc; 2006 Aug; 54(8):1245-50. PubMed ID: 16913993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Strategies to improve tolerability of rivastigmine: a case series.
    Venkatesh K; Bullock R; Akbaş A
    Curr Med Res Opin; 2007 Jan; 23(1):93-5. PubMed ID: 17257470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rivastigmine in the treatment of delirium in older people: a pilot study.
    Overshott R; Vernon M; Morris J; Burns A
    Int Psychogeriatr; 2010 Aug; 22(5):812-8. PubMed ID: 20353624
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of rivastigmine on the quantitative EEG in demented Parkinsonian patients.
    Fogelson N; Kogan E; Korczyn AD; Giladi N; Shabtai H; Neufeld MY
    Acta Neurol Scand; 2003 Apr; 107(4):252-5. PubMed ID: 12675697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rivastigmine treatment of Othello syndrome and post-ECT delirium in a patient with Parkinson's disease.
    Scicutella A
    J Neuropsychiatry Clin Neurosci; 2015; 27(1):e90. PubMed ID: 25716514
    [No Abstract]   [Full Text] [Related]  

  • 53. Cholinesterase inhibitors and delirium after cardiac surgery.
    Yazigi A; Madi-Jebara S; Haddad F; Hayek G
    Crit Care Med; 2010 Apr; 38(4):1231. PubMed ID: 20335721
    [No Abstract]   [Full Text] [Related]  

  • 54. Rivastigmine superior to aspirin plus nimodipine in subcortical vascular dementia: an open, 16-month, comparative study.
    Moretti R; Torre P; Antonello RM; Cazzato G; Griggio S; Ukmar M; Bava A
    Int J Clin Pract; 2004 Apr; 58(4):346-53. PubMed ID: 15161118
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rivastigmine in the treatment of Huntington's disease.
    Rot U; Kobal J; Sever A; Pirtosek Z; Mesec A
    Eur J Neurol; 2002 Nov; 9(6):689-90. PubMed ID: 12453090
    [No Abstract]   [Full Text] [Related]  

  • 56. Rivastigmine patch reduces the incidence of postoperative delirium in older patients with cognitive impairment.
    Youn YC; Shin HW; Choi BS; Kim S; Lee JY; Ha YC
    Int J Geriatr Psychiatry; 2017 Oct; 32(10):1079-1084. PubMed ID: 27561376
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preventing delirium in an acute hospital using a non-pharmacological intervention.
    Martinez FT; Tobar C; Beddings CI; Vallejo G; Fuentes P
    Age Ageing; 2012 Sep; 41(5):629-34. PubMed ID: 22589080
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of rivastigmine on sleep in elderly healthy subjects.
    Schredl M; Weber B; Braus D; Gattaz WF; Berger M; Riemann D; Heuser I
    Exp Gerontol; 2000 Mar; 35(2):243-9. PubMed ID: 10767583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of rivastigmine on post-surgical delirium and cognitive impairment; a randomized clinical trial.
    Massoudi N; Mohit B; Fathi M; Nooraei N; Hannani KK; ArianNik M
    Int J Geriatr Psychiatry; 2023 Jul; 38(7):e5970. PubMed ID: 37485727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An educational intervention can prevent delirium on acute medical wards.
    Tabet N; Hudson S; Sweeney V; Sauer J; Bryant C; Macdonald A; Howard R
    Age Ageing; 2005 Mar; 34(2):152-6. PubMed ID: 15713859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.